These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23293898)

  • 1. Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials.
    Abbasowa L; Kessing LV; Vinberg M
    Nord J Psychiatry; 2013 Dec; 67(6):369-82. PubMed ID: 23293898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis.
    McIntyre RS; Lee Y; Zhou AJ; Rosenblat JD; Peters EM; Lam RW; Kennedy SH; Rong C; Jerrell JM
    J Clin Psychopharmacol; 2017 Aug; 37(4):412-418. PubMed ID: 28590365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the use of stimulants and stimulant alternatives in treating bipolar depression and major depressive disorder.
    Corp SA; Gitlin MJ; Altshuler LL
    J Clin Psychiatry; 2014 Sep; 75(9):1010-8. PubMed ID: 25295426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: a medium-term evaluation of cost benefits.
    Parker G; Brotchie H; McClure G; Fletcher K
    J Affect Disord; 2013 Oct; 151(1):360-4. PubMed ID: 23810360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulants in the treatment of depression : a review of the evidence.
    Orr K; Taylor D
    CNS Drugs; 2007; 21(3):239-57. PubMed ID: 17338594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.
    Faridhosseini F; Sadeghi R; Farid L; Pourgholami M
    Hum Psychopharmacol; 2014 May; 29(3):216-23. PubMed ID: 24911574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential Procognitive Effects of Modafinil in Major Depressive Disorder: A Systematic Review.
    Vaccarino SR; McInerney SJ; Kennedy SH; Bhat V
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31599501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the old psychostimulant drugs have a role in managing treatment-resistant depression?
    Parker G; Brotchie H
    Acta Psychiatr Scand; 2010 Apr; 121(4):308-14. PubMed ID: 19594481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modafinil in the treatment of depression].
    Videbech P
    Ugeskr Laeger; 2012 Feb; 174(6):348-51. PubMed ID: 22310006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis.
    Tardelli VS; Bisaga A; Arcadepani FB; Gerra G; Levin FR; Fidalgo TM
    Psychopharmacology (Berl); 2020 Aug; 237(8):2233-2255. PubMed ID: 32601988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychostimulants for late life depression].
    Delsalle P; Schuster JP; von Gunten A; Limosin F
    Encephale; 2018 Jun; 44(3):274-279. PubMed ID: 29195804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of psychostimulants in general psychiatry. A reconsideration.
    Chiarello RJ; Cole JO
    Arch Gen Psychiatry; 1987 Mar; 44(3):286-95. PubMed ID: 2881528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of lisdexamfetamine as an antidepressant augmentation strategy: A meta-analysis of randomized controlled trials.
    Giacobbe P; Rakita U; Lam R; Milev R; Kennedy SH; McIntyre RS
    J Affect Disord; 2018 Jan; 226():294-300. PubMed ID: 29028590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychostimulants and treatment resistant depression.
    Ng B
    Acta Psychiatr Scand; 2009 Dec; 120(6):502-3; author reply 503. PubMed ID: 19824985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.